insights_auto
Why is INO down 10.49%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.45
arrow_downward
-10.49%(-0.17) 1D
$1.18
arrow_downward
-18.97% (-0.28)bedtimeAfter hours
Closed: Nov 5, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.57
High
$1.59
Low
$1.40
Mkt. cap
149.93M
Avg. vol.
15.72M
Volume
16.30M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
Open
$1.57
High
$1.59
Low
$1.40
Mkt. cap
149.93M
Avg. vol.
15.72M
Volume
16.30M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
News Corp
·
1 hour ago
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Investing.com
·
2 hours ago
Inovio announces proposed public offering of common stock
Benzinga
·
2 hours ago
12 Health Care Stocks Moving In Thursday's After-Market Session
TradingView
·
2 hours ago
INOVIO Announces Proposed Public Offering of its Common Stock
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com